Investor Presentation Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investors Presentation Q4 FY26
Investor Presentation Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Marksans Investors Presentation Q3 and 9M FY 26
Investor Presentation Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Marksans Pharma Limited Investor Presentation for Q2 FY26
Investor Presentation Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation of Q1 FY 26
Investor Presentation Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation attached
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Kindly find enclosed investor presentation
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India PFA
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Kindly find enclosed
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on financial results for FY24
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation on financial results for quarter ended December 31, 2024